300244 Stock Overview
Operates as a third-party independent medical diagnostic service company in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Dian Diagnostics Group Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.45 |
| 52 Week High | CN¥21.20 |
| 52 Week Low | CN¥8.90 |
| Beta | 0.59 |
| 1 Month Change | -7.93% |
| 3 Month Change | -15.11% |
| 1 Year Change | -36.55% |
| 3 Year Change | -64.27% |
| 5 Year Change | -64.26% |
| Change since IPO | 131.88% |
Recent News & Updates
Dian Diagnostics GroupLtd (SZSE:300244) Will Want To Turn Around Its Return Trends
Jan 02
Here's Why Dian Diagnostics GroupLtd (SZSE:300244) Can Manage Its Debt Responsibly
Dec 12Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Shares Bounce 37% But Its Business Still Trails The Industry
Oct 04Recent updates
Dian Diagnostics GroupLtd (SZSE:300244) Will Want To Turn Around Its Return Trends
Jan 02Here's Why Dian Diagnostics GroupLtd (SZSE:300244) Can Manage Its Debt Responsibly
Dec 12Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Shares Bounce 37% But Its Business Still Trails The Industry
Oct 04Dian Diagnostics Group Co.,Ltd. (SZSE:300244) Looks Inexpensive But Perhaps Not Attractive Enough
Aug 20Returns On Capital Signal Tricky Times Ahead For Dian Diagnostics GroupLtd (SZSE:300244)
Jul 12Dian Diagnostics GroupLtd (SZSE:300244) Will Pay A Smaller Dividend Than Last Year
Jun 10Dian Diagnostics GroupLtd (SZSE:300244) Seems To Use Debt Quite Sensibly
May 24Dian Diagnostics Group Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Apr 30Investors Holding Back On Dian Diagnostics Group Co.,Ltd. (SZSE:300244)
Apr 22Shareholder Returns
| 300244 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -2.2% | 0.4% | -0.9% |
| 1Y | -36.6% | -0.9% | 22.0% |
Return vs Industry: 300244 underperformed the CN Healthcare industry which returned -3.6% over the past year.
Return vs Market: 300244 underperformed the CN Market which returned 18.4% over the past year.
Price Volatility
| 300244 volatility | |
|---|---|
| 300244 Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in CN Market | 10.7% |
| 10% least volatile stocks in CN Market | 4.0% |
Stable Share Price: 300244 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300244's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 10,843 | Haibin Chen | www.dazd.cn |
Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions.
Dian Diagnostics Group Co.,Ltd. Fundamentals Summary
| 300244 fundamental statistics | |
|---|---|
| Market cap | CN¥6.39b |
| Earnings (TTM) | -CN¥92.56m |
| Revenue (TTM) | CN¥12.37b |
0.5x
P/S Ratio-69.0x
P/E RatioIs 300244 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300244 income statement (TTM) | |
|---|---|
| Revenue | CN¥12.37b |
| Cost of Revenue | CN¥9.00b |
| Gross Profit | CN¥3.37b |
| Other Expenses | CN¥3.46b |
| Earnings | -CN¥92.56m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 23, 2025
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 27.25% |
| Net Profit Margin | -0.75% |
| Debt/Equity Ratio | 39.9% |
How did 300244 perform over the long term?
See historical performance and comparisonDividends
6.2%
Current Dividend Yield-474%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 04:06 |
| End of Day Share Price | 2025/01/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dian Diagnostics Group Co.,Ltd. is covered by 19 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Yolanda Yin | China Galaxy International Securities (Hong Kong) |
| Pei Cheng | China Galaxy Securities Co., Ltd. |